Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TNFRSF4 Mouse anti-Human, Clone:8H6H7, Abnova™

Mouse monoclonal antibody raised against partial recombinant human TNFRSF4.

Supplier:  Abnova Corporation MAB17973

Catalog No. 89-334-326


Only null left
Add to Cart

Description

Description

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation. [provided by RefSeq]
Specifications

Specifications

TNFRSF4
Monoclonal
Unconjugated
ELISA (1:10000)
Western Blot (1:100-1:500)
The optimal working dilution should be determined by the end user.
TNFRSF4
Mouse
100 μg
Human
Antibody
IgG1
ELISA, Western Blot
8H6H7
tumor necrosis factor receptor superfamily, member 4
In PBS (0.05% sodium azide)
ACT35, CD134, OX40, TXGP1L
Recombinant protein corresponding to amino acids 29-214 of human TNFRSF4.
7293
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.